Advances in computational nephropathology
Kidney International, vol. 108, pp. 1031–1044
Abstract
Pathology relies on pathologists' qualitative assessment and semiquantitative measures to characterize the structural and molecular alterations of tissues. Novel analytical methods and recent advances in the computational field, particularly in artificial intelligence and deep learning in pathology, termed computational pathology, have led to widespread applications and advancement in research. Integrating computational approaches into the digital pathology workflow can facilitate the automated, high-throughput analysis of histopathologic images, thereby improving precision, reproducibility, and efficiency in pathology diagnostics. We provide a comprehensive overview of the advancements and applications of computational pathology, specifically in nephropathology. We discuss widely adopted methodological approaches, highlighting their respective strengths and limitations, including quantitative nephropathology (i.e., pathomics), deep learning-based image classification and regression, and nonimage applications (e.g., automated decision support systems for standardizing the reporting of current consensus classifications). Despite the promising potential of these approaches, several challenges remain for successful implementation in routine clinical practice. We highlight technological, regulatory, and ethical challenges, such as computational infrastructure, data privacy, and considerations of environmental sustainability. Looking toward the future, we envisage potential developments that could further transform the field. We are entering a new exciting era, where computational methods are reshaping and redefining kidney pathology, perhaps also renaming our field to "kidnAI" pathology.
Authors 4
-
David Laurin Hölscher Aachen Institute for Pathology Department for Nephrology and Clinical Immunology
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Institute for Pathology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany; Department for Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany
Institute for Pathology, RWTH Aachen University Hospital, Aachen, Germany; Department for Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Aachen, Germany
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Institute for Pathology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany
Institute for Pathology, RWTH Aachen University Hospital, Aachen, Germany
-
Universitätsklinikum Aachen · RWTH Aachen University
Affiliation as printed
Institute for Pathology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany
Institute for Pathology, RWTH Aachen University Hospital, Aachen, Germany
-
Peter Boor Aachen Institute for Pathology Department for Nephrology and Clinical Immunology Electron Microscopy Facility
Universitätsklinikum Aachen · Comenius University Bratislava · RWTH Aachen University
Affiliation as printed
Institute for Pathology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany; Department for Nephrology and Clinical Immunology, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany; Electron Microscopy Facility, Rheinisch-Westfälische Technische Hochschule Aachen University Hospital, Aachen, Germany; Institute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia. Electronic address: pboor@ukaachen.de
Institute for Pathology, RWTH Aachen University Hospital, Aachen, Germany; Department for Nephrology and Clinical Immunology, RWTH Aachen University Hospital, Aachen, Germany; Electron Microscopy Facility, RWTH Aachen University Hospital, Aachen, Germany. Electronic address: pboor@ukaachen.de
Cited by 17 stored of 17
17 results
No patents citing this paper on Lens.org (checked 2026-10-06).